Seres Therapeutics, Inc. · NASDAQ:MCRB
Henn Matthew R sold 81 Seres Therapeutics, Inc. shares (Form 4)
Traded Aug 15 to Aug 17, 2026 · Filed Aug 18, 2026
From Aug 15 to Aug 17, 2026, Henn Matthew R (See Remarks) sold 81 Seres Therapeutics, Inc. shares at US$4.55 for US$369 under a trading plan, leaving 7,995 shares. Filed Aug 18, 2026 (Form 4).
- Sold
- 81 shares
- Price
- US$4.55
- Value
- US$369
- Holding after
- 7,995 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 15, 2026 | Common Stock | Option exercise | 238 | 8,076 | Direct | |
| Aug 17, 2026 | Common Stock | Sale | 81 | US$4.55 | 7,995 | Direct |